TMCnet News
Research and Markets: Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H1, 2014 ReportDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/3m59wb/anaplastic_large) has announced the addition of the "Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H1, 2014" report to their offering. Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H1, 2014" provides data on the Anaplastic Large Cell Lymphoma (ALCL) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anaplastic Large Cell Lymphoma (ALCL) . It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of rials for the key drugs for treating Anaplastic Large Cell Lymphoma (ALCL). Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Key Topics Covered: List of Tables List of Figures Introduction Anaplastic Large Cell Lymphoma (ALCL) Report Guidance Clinical Trials by Region Clinical Trials and Average Enrollment by Country Clinical Trials by G7 Countries: Proportion of Anaplastic Large Cell Lymphoma (ALCL) to Oncology Clinical Trials In Progress Trials by Phase Clinical Trials by Trial Status Clinical Trials by End Point Status Unaccomplished Trials of Anaplastic Large Cell Lymphoma (ALCL) Subjects Recruited Over a Period of Time Clinical Trials by Sponsor Type Prominent Sponsors Top Companies Participating in Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials Prominent Drugs Five Key Clinical Profiles Appendix For more information visit http://www.researchandmarkets.com/research/3m59wb/anaplastic_large About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
|